These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22267099)

  • 1. Using the antinuclear antibody test to diagnose rheumatic diseases: when does a positive test warrant further investigation?
    Volkmann ER; Taylor M; Ben-Artzi A
    South Med J; 2012 Feb; 105(2):100-4. PubMed ID: 22267099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antinuclear antibodies by the Inno-Lia ANA update test in canine systemic rheumatic disease.
    Hansson-Hamlin H; Rönnelid J
    Vet Clin Pathol; 2010 Jun; 39(2):215-20. PubMed ID: 19886972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
    Mariz HA; Sato EI; Barbosa SH; Rodrigues SH; Dellavance A; Andrade LE
    Arthritis Rheum; 2011 Jan; 63(1):191-200. PubMed ID: 20954189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinuclear antibody testing. A study of clinical utility.
    Slater CA; Davis RB; Shmerling RH
    Arch Intern Med; 1996 Jul; 156(13):1421-5. PubMed ID: 8678710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antinuclear antibody test. When is a positive result clinically relevant?
    Thomas C; Robinson JA
    Postgrad Med; 1993 Aug; 94(2):55-8, 63, 66. PubMed ID: 8341626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical utility of a positive antinuclear antibody test result.
    Abeles AM; Abeles M
    Am J Med; 2013 Apr; 126(4):342-8. PubMed ID: 23395534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes.
    Solans-Laqué R; Pérez-Bocanegra C; Salud-Salvia A; Fonollosa-Plá V; Rodrigo MJ; Armadans L; Simeón-Aznar CP; Vilardell-Tarres M
    Lupus; 2004; 13(3):159-64. PubMed ID: 15119543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
    Tipu HN; Bashir MM
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of antinuclear antibodies in rheumatic diseases].
    Endresen GK; Mellbye OJ
    Tidsskr Nor Laegeforen; 1991 Feb; 111(6):716-9. PubMed ID: 2008695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
    Sebastian W; Roy A; Kini U; Mullick S
    Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative study of antinuclear antibody measurement using different cells as nuclear substrates].
    Yang JS; Hsieh RP; Shen MC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):299-310. PubMed ID: 1818799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of tests for antinuclear antibodies (ANA) in rheumatic diseases.
    Nakamura RN; Tan EM
    West J Med; 1978 Jan; 128(1):51-2. PubMed ID: 415436
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of antinuclear antibodies in rheumatology].
    Ciobanu V; Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):97-111. PubMed ID: 2875509
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of the immunofluorescence staining patterns and titres of the antinuclear antibody test in paediatric rheumatology setting.
    Baba Ö; Kısaoğlu H; Kalyoncu M
    Turk J Med Sci; 2023 Feb; 53(1):193-198. PubMed ID: 36945955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basics in standardization and practical applications of immunofluorescent microscopy: standardization of antinuclear antibody tests.
    Beutner EH; Kumar V; Greenlee P
    Lab Res Methods Biol Med; 1983; 8():49-70. PubMed ID: 6358746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of anti-nuclear antibodies by indirect immunofluorescence on HEp-2 cells: setting the appropriate screening dilution for the diagnosis of autoimmune rheumatic diseases.
    Brito Fde A; Santos SM; Ferreira GA; Pedrosa W; Gradisse J; Costa LC; Neves SP
    Rev Bras Reumatol; 2014; 54(1):13-20. PubMed ID: 24878786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody testing: procedures and significance in systemic rheumatic diseases.
    Fritzler MJ
    Methods Achiev Exp Pathol; 1986; 12():224-60. PubMed ID: 3083214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases.
    Bossuyt X; De Langhe E; Borghi MO; Meroni PL
    Nat Rev Rheumatol; 2020 Dec; 16(12):715-726. PubMed ID: 33154583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.